Karol Miszalski-Jamka

Karol Miszalski-Jamka

Auto-generated profile, based on publicly available information

Karol Miszalski-Jamka

Graylight Imaging

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Circulation: Cardiovascular Genetics
Verified
Journal Article
Open access
PDF file
KMKarol Miszalski-Jamka
Karol Miszalski-Jamka
JJJohn L. Jefferies
John L. Jefferies
WMWojciech Mazur
Wojciech Mazur
JGJan Głowacki
Jan Głowacki
JHJianhong Hu
Jianhong Hu
MBMatthew N. Bainbridge
Matthew N. Bainbridge
Background—: Left ventricular noncompaction (LVNC) is a genetically and phenotypically heterogeneous disease and, although increasingly recognized in clinical practice, there is a lack of widely accepted diagnostic criteria. We sought to identify novel genetic causes of LVNC and describe genotype–phenotype correlations. Methods and Results—: A total of 190 patients from 174 families with left ventricular hypertrabeculation (LVHT) or LVNC were referred for cardiac magnetic resonance and whole-exome sequencing. A total of 425 control individuals were included to identify variants of interest (VOIs). We found an excess of 138 VOIs in 102 (59%) unrelated patients in 54 previously identified LVNC or other known cardiomyopathy genes. VOIs were found in 68 of 90 probands with LVNC and 34 of 84 probands with LVHT (76% and 40%, respectively; P <0.001). We identified 0, 1, and ≥2 VOIs in 72, 74, and 28 probands, respectively. We found increasing number of VOIs in a patient strongly correlated with several markers of disease severity, including ratio of noncompacted to compacted myocardium ( P <0.001) and left ventricular ejection fraction ( P =0.01). The presence of sarcomeric gene mutations was associated with increased occurrence of late gadolinium enhancement ( P =0.004). Conclusions—: LVHT and LVNC likely represent a continuum of genotypic disease with differences in severity and variable phenotype explained, in part, by the number of VOIs and whether mutations are present in sarcomeric or nonsarcomeric genes. Presence of VOIs is common in patients with LVHT. Our findings expand the current clinical and genetic diagnostic approaches for patients with LVHT and LVNC.

1 October 2015 in Cancer Epidemiology
Verified
Journal Article
Closed access
BHBartosz Hudzik
Bartosz Hudzik
KMKarol Miszalski-Jamka
Karol Miszalski-Jamka
JGJan Glowacki
Jan Glowacki
ALAndrzej Lekston
Andrzej Lekston
MGMarek Gierlotka
Marek Gierlotka
MGMariusz Gasior
Mariusz Gasior

14 August 2017 in Genome Medicine
Verified
Journal Article
Open access
PDF file
MNMembers Of The Undiagnosed Diseases Network
Members Of The Undiagnosed Diseases Network
BBBret L. Bostwick
Bret L. Bostwick
SMScott McLean
Scott McLean
JPJennifer E. Posey
Jennifer E. Posey
HSHaley E. Streff
Haley E. Streff
SLSeema R. Lalani
Seema R. Lalani
De novo missense variants in CDK13 have been described as the cause of syndromic congenital heart defects in seven individuals ascertained from a large congenital cardiovascular malformations cohort. We aimed to further define the phenotypic and molecular spectrum of this newly described disorder. To minimise ascertainment bias, we recruited nine additional individuals with CDK13 pathogenic variants from clinical and research exome laboratory sequencing cohorts. Each individual underwent dysmorphology exam and comprehensive medical history review. We demonstrate greater than expected phenotypic heterogeneity, including 33% (3/9) of individuals without structural heart disease on echocardiogram. There was a high penetrance for a unique constellation of facial dysmorphism and global developmental delay, as well as less frequently seen renal and sacral anomalies. Two individuals had novel CDK13 variants (p.Asn842Asp, p.Lys734Glu), while the remaining seven unrelated individuals had a recurrent, previously published p.Asn842Ser variant. Summary of all variants published to date demonstrates apparent restriction of pathogenic variants to the protein kinase domain with clustering in the ATP and magnesium binding sites. Here we provide detailed phenotypic and molecular characterisation of individuals with pathogenic variants in CDK13 and propose management guidelines based upon the estimated prevalence of anomalies identified.

23 July 2011 in European Radiology
Verified
Journal Article
Open access
PDF file
TMTomasz Miszalski-Jamka
Tomasz Miszalski-Jamka
WSWojciech Szczeklik
Wojciech Szczeklik
BSBarbara Sokołowska
Barbara Sokołowska
KMKarol Miszalski-Jamka
Karol Miszalski-Jamka
KKKrzysztof Karwat
Krzysztof Karwat
JMJacek Musiał
Jacek Musiał
Objectives The aim of the study was to assess cardiac involvement in patients with Wegener’s granulomatosis (WG), who failed to achieve remission following >6 months induction therapy for life or organ threatening disease. Methods Eleven WG patients (eight males, mean age 47 ± 13 years), who failed to achieve remission despite >6 months induction therapy, underwent transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR). Results Cardiac involvement was present in 9 (82%) patients. Regional wall motion abnormalities were found in two individuals, but none had left ventricular (LV) ejection fraction 6 months induction therapy cardiac involvement is frequent and is characterized by foci of LGE lesions and signs of myocardial inflammatory process.

1 November 2009 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
TMTomasz Miszalski-Jamka
Tomasz Miszalski-Jamka
SKStefanie Kuntz-Hehner
Stefanie Kuntz-Hehner
HSHarald Schmidt
Harald Schmidt
DPDaniel Peter
Daniel Peter
KMKarol Miszalski-Jamka
Karol Miszalski-Jamka
HOHeyder Omran
Heyder Omran

1 January 2015 in JACC
Verified
Journal Article
Closed access
TMTomasz Miszalski-Jamka
Tomasz Miszalski-Jamka
WSWojciech Szczeklik
Wojciech Szczeklik
BSBarbara Sokołowska
Barbara Sokołowska
KKKrzysztof Karwat
Krzysztof Karwat
KMKarol Miszalski-Jamka
Karol Miszalski-Jamka
JMJacek Musiał
Jacek Musiał